Elagolix + placebo
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Endometriosis, Pain
Conditions
Endometriosis, Pain
Trial Timeline
Feb 19, 2008 → Aug 28, 2009
NCT ID
NCT00619866About Elagolix + placebo
Elagolix + placebo is a phase 2 stage product being developed by AbbVie for Endometriosis, Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT00619866. Target conditions include Endometriosis, Pain.
What happened to similar drugs?
1 of 19 similar drugs in Endometriosis, Pain were approved
Approved (1) Terminated (3) Active (15)
Hype Score Breakdown
Clinical
12
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03951077 | Phase 2 | Completed |
| NCT03886220 | Approved | Completed |
| NCT00619866 | Phase 2 | Completed |
Competing Products
20 competing products in Endometriosis, Pain